Remission is commonly misconstrued as a definitive endpoint, yet many survivors experience lasting physiologic and psychosocial sequelae that preclude a return to pre-diagnosis “normal.” ...
The U.S. Food and Drug Administration’s approval of Rasonque (daraxonrasib) represents an important advance for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results